Astegolimab

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

120 competitors in Chronic Obstructive Pulmonary Disease

#DrugCompanyPhaseTrials

1

EXDENSUR

GGlaxo Dba Glaxosmithkline

Phase 3

22

Lunsekimig

Sanofi

Phase 3

33

Tozorakimab

AstraZeneca

Phase 3

24

CM310

KKeymed Biosciences Co.Ltd

Phase 3

15

CM512

KKeymed Biosciences Co.Ltd

Phase 2

16

Astegolimab

Roche

Phase 3

37

Titrated Oxygen

RRigshospitalet, Denmark

Phase 3

18

HSK39004

Haisco Pharmaceutical Group Co., Ltd.

Phase 2

29

RLS-0071

RReAlta Life Sciences, Inc.

Phase 2

110

Calciferol

Jazz Pharmaceuticals

Preclinical

—Show 29 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Chronic Obstructive Pulmonary Disease3 trials

A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Completed·Roche·Phase 2·NCT05037929·1,334 enrolled

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Recruiting·Roche·Phase 3·NCT05595642·1,290 enrolled

A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

Active, not recruiting·Roche·Phase 3·NCT05878769·2,000 enrolled

Unspecified1 trial

A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects

Completed·Roche·Phase 1·NCT06462118·78 enrolled

Details

Drug Info

Related News